Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950134-05-005924
Filing Date
2005-03-24
Accepted
2005-03-24 17:02:00
Documents
2
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO FORM 10-K f07096ae10vkza.htm 10-K/A 103725
2 EXHIBIT 31.2 f07096aexv31w2.htm EX-31.2 2633
  Complete submission text file 0000950134-05-005924.txt   108013
Mailing Address 2100 POWELL STREET EMERYVILLE CA 94608
Business Address 2100 POWELL STREET EMERYVILLE CA 94608 5105976500
ONYX PHARMACEUTICALS INC (Filer) CIK: 0001012140 (see all company filings)

EIN.: 943154463 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-28298 | Film No.: 05702608
SIC: 2836 Biological Products, (No Diagnostic Substances)